NADAC acquisition cost data for ACYCLOVIR 200 MG/5 ML SUSP. This is a generic medication, typically more affordable than brand-name equivalents.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 00378871273 | $0.1545 | 2022-12-21 | Rx |
| 00472008216 | $0.1545 | 2022-12-21 | Rx |
| 23155048551 | $0.1545 | 2022-12-21 | Rx |
| 31722068147 | $0.1545 | 2022-12-21 | Rx |
| 50383081016 | $0.1545 | 2022-12-21 | Rx |
| 66689034216 | $0.1545 | 2022-12-21 | Rx |
| 70954018810 | $0.1545 | 2022-12-21 | Rx |
| 00378871273 | $0.1545 | 2022-12-21 | Rx |
| 00472008216 | $0.1545 | 2022-12-21 | Rx |
| 23155048551 | $0.1545 | 2022-12-21 | Rx |
Generic: Acyclovir Sodium | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $62.8K | 299 | 112 | $0.7997 |
| 2020 | $53.0K | 248 | 124 | $0.5894 |
| 2021 | $36.1K | 195 | 85 | $0.4725 |
| 2022 | $55.1K | 269 | 112 | $0.9822 |
| 2023 | $46.6K | 234 | 103 | $1.13 |
| State | Total Cost | Claims | Beneficiaries |
|---|---|---|---|
| California | $9.3K | 62 | 28 |
| Florida | $5.9K | 26 | N/A |
| Ohio | $4.7K | 14 | N/A |
| Michigan | $2.6K | 11 | N/A |
| Kentucky | $2.3K | 14 | N/A |
| Illinois | $1.8K | 15 | N/A |
| New York | $1.6K | 11 | N/A |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.